ADMA Biologics Inc (ADMA)
6.52
-0.06
(-0.91%)
USD |
NASDAQ |
Apr 30, 16:00
6.51
-0.01
(-0.15%)
After-Hours: 20:00
ADMA Biologics Cash from Investing (TTM): -4.981M for Dec. 31, 2023
Cash from Investing (TTM) Chart
Historical Cash from Investing (TTM) Data
Date | Value |
---|---|
December 31, 2023 | -4.981M |
September 30, 2023 | -7.322M |
June 30, 2023 | -9.946M |
March 31, 2023 | -13.01M |
December 31, 2022 | -13.91M |
September 30, 2022 | -13.84M |
June 30, 2022 | -13.25M |
March 31, 2022 | -13.78M |
December 31, 2021 | -13.51M |
September 30, 2021 | -13.43M |
June 30, 2021 | -13.53M |
March 31, 2021 | -13.22M |
December 31, 2020 | -12.72M |
September 30, 2020 | -10.72M |
June 30, 2020 | -9.807M |
March 31, 2020 | -5.774M |
December 31, 2019 | -3.812M |
September 30, 2019 | -3.036M |
June 30, 2019 | -1.295M |
March 31, 2019 | -1.657M |
December 31, 2018 | -2.096M |
September 30, 2018 | -3.286M |
June 30, 2018 | -3.626M |
March 31, 2018 | 9.523M |
December 31, 2017 | 15.21M |
Date | Value |
---|---|
September 30, 2017 | 22.85M |
June 30, 2017 | 23.66M |
March 31, 2017 | 2.390M |
December 31, 2016 | 0.9046M |
September 30, 2016 | 0.6788M |
June 30, 2016 | 4.597M |
March 31, 2016 | 8.788M |
December 31, 2015 | -1.742M |
September 30, 2015 | -6.032M |
June 30, 2015 | -11.59M |
March 31, 2015 | -11.53M |
December 31, 2014 | -4.041M |
September 30, 2014 | -8.092M |
June 30, 2014 | -6.706M |
March 31, 2014 | -2.446M |
December 31, 2013 | -3.132M |
September 30, 2013 | -0.2265M |
June 30, 2013 | -0.2375M |
March 31, 2013 | -0.1849M |
December 31, 2012 | -0.1189M |
September 30, 2012 | -0.0835M |
June 30, 2012 | -0.0562M |
March 31, 2012 | 0.00 |
December 31, 2011 | 0.00 |
September 30, 2011 | 0.00 |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (TTM) Range, Past 5 Years
-13.91M
Minimum
Dec 2022
-1.295M
Maximum
Jun 2019
-10.05M
Average
-12.72M
Median
Dec 2020
Cash from Investing (TTM) Benchmarks
Vanda Pharmaceuticals Inc | -12.06M |
ANI Pharmaceuticals Inc | -18.51M |
Ligand Pharmaceuticals Inc | -11.68M |
Puma Biotechnology Inc | -19.12M |
Bristol-Myers Squibb Co | -21.70B |